Literature DB >> 2555194

Characterization of a membrane-associated phosphotyrosyl protein phosphatase from the A431 human epidermoid carcinoma cell line.

M T Bütler1, A Ziemiecki, B Groner, R R Friis.   

Abstract

The A431 human epidermoid carcinoma cell line exhibits a 30-100-fold overexpression of the epidermal growth factor (EGF) receptor. We have characterized a membrane-associated phosphotyrosyl-protein phosphatase (PTPase) in these cells since it seemed reasonable that overexpression of the EGF-receptor tyrosine kinase will be matched by high PTPase activity. Indeed, of 12 cell lines tested, the A431 cells had the highest specific PTPase activity. About 70% of the total cellular PTPase activity was found associated with membranes after cell fractionation. The membrane-associated PTPase was hydrophobic as judged by its behaviour in Triton X-114 phase partitioning. High-performance liquid chromatography (HPLC) on a DEAE column revealed a single, homogeneous species of membrane-associated PTPase with an apparent molecular mass of 43 kDa as determined by HPLC on a gel permeation column in the presence of Triton X-100. Comparison of this PTPase with the membrane-associated PTPase activities present in rat spleen and in the human chronic myelogenous leukemia cell line K562 revealed additional species resolvable by DEAE-HPLC. These findings suggest that cells may possess different PTPase activities depending on their growth and differentiation states.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555194     DOI: 10.1111/j.1432-1033.1989.tb15139.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells.

Authors:  B Payrastre; M Plantavid; M Breton; E Chambaz; H Chap
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice.

Authors:  M W Kunkel; K E Hook; C T Howard; S Przybranowski; B J Roberts; W L Elliott; W R Leopold
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma.

Authors:  D Rotin; B Margolis; M Mohammadi; R J Daly; G Daum; N Li; E H Fischer; W H Burgess; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

4.  Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).

Authors:  M Ciomei; W Pastori; L Capolongo; C Geroni; G Melegaro; G Pennella; M Grandi
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.